Cargando…
Ongoing Developments in Sporadic Inclusion Body Myositis
Sporadic inclusion body myositis (IBM) is an acquired muscle disorder associated with ageing, for which there is no effective treatment. Ongoing developments include: genetic studies that may provide insights regarding the pathogenesis of IBM, improved histopathological markers, the description of a...
Autores principales: | Machado, Pedro M., Ahmed, Mhoriam, Brady, Stefen, Gang, Qiang, Healy, Estelle, Morrow, Jasper M., Wallace, Amanda C., Dewar, Liz, Ramdharry, Gita, Parton, Matthew, Holton, Janice L., Houlden, Henry, Greensmith, Linda, Hanna, Michael G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233319/ https://www.ncbi.nlm.nih.gov/pubmed/25399751 http://dx.doi.org/10.1007/s11926-014-0477-9 |
Ejemplares similares
-
Update in inclusion body myositis
por: Machado, Pedro, et al.
Publicado: (2013) -
Widespread RNA metabolism impairment in sporadic inclusion body myositis TDP43-proteinopathy()
por: Cortese, Andrea, et al.
Publicado: (2014) -
The effects of an intronic polymorphism in TOMM40 and APOE genotypes in sporadic inclusion body myositis
por: Gang, Qiang, et al.
Publicado: (2015) -
Rare variants in SQSTM1 and VCP genes and risk of sporadic inclusion body myositis
por: Gang, Qiang, et al.
Publicado: (2016) -
The Ca(2+) sensitizer CK‐2066260 increases myofibrillar Ca(2+) sensitivity and submaximal force selectively in fast skeletal muscle
por: Hwee, Darren T., et al.
Publicado: (2017)